Literature DB >> 6733362

An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.

K A Kane, J R Parratt, F M Williams.   

Abstract

Reperfusion-induced arrhythmias were elicited in the pentobarbitone-anaesthetized rat by occlusion of the left main coronary artery and subsequent release. These arrhythmias were rapid in onset, occurring within 20 s after release of the ligature, and were of short duration (1-2 min). Their severity was dependent upon the duration of the preceding occlusion. A 5 or 15 min occlusion period produced the most severe arrhythmias on release, the incidence of ventricular fibrillation being 56 and 50% respectively. Evidence that reperfusion had occurred was provided by fluorescein dye distribution and intramyocardial temperature studies. The severity of reperfusion arrhythmias and mortality was unaffected by bilateral vagotomy, beta-adrenoceptor blockade by atenolol (2 mg kg-1 i.v.) or a combination of the two. The incidence of reperfusion-induced ventricular fibrillation was significantly reduced by Org 6001 (which blocks the fast inward sodium current), melperone (which acutely prolongs the cardiac action potential duration) and bepridil (which blocks both fast and slow inward currents). It was unaffected by nitroglycerine and the calcium antagonists verapamil, prenylamine and nifedipine. We have shown that reperfusion-induced cardiac arrhythmias can be consistently elicited in the anaesthetized rat and that they are particularly susceptible to drugs that can block the fast inward sodium current.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733362      PMCID: PMC1987024          DOI: 10.1111/j.1476-5381.1984.tb10769.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.

Authors:  L A Salako; V Williams; J H Wittig
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

2.  Ventricular fibrillation in dogs after sudden return of flow to the coronary artery.

Authors:  W H SEWELL; D R KOTH; C E HUGGINS
Journal:  Surgery       Date:  1955-12       Impact factor: 3.982

3.  Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.

Authors:  P Arlock; B Gullberg; S R Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

4.  Role of the nervous system in the arrhythmias produced by coronary occlusion in the cat.

Authors:  R A Gillis
Journal:  Am Heart J       Date:  1971-05       Impact factor: 4.749

5.  Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats.

Authors:  D J Sheridan; P A Penkoske; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

6.  Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release.

Authors:  P J Axelrod; R L Verrier; B Lown
Journal:  Am J Cardiol       Date:  1975-11       Impact factor: 2.778

7.  Pre- and postsynaptic alpha-adrenoceptor antagonism by neuroleptics in vivo.

Authors:  E N Petersen
Journal:  Eur J Pharmacol       Date:  1981-02-19       Impact factor: 4.432

8.  Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil.

Authors:  K A Kane; E Winslow
Journal:  J Cardiovasc Pharmacol       Date:  1980       Impact factor: 3.105

9.  Nifedipine reduces arrhythmias but does not alter prostanoid release during coronary artery occlusion and reperfusion in anaesthetised greyhounds.

Authors:  S J Coker; J R Parratt
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

10.  Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

Authors:  C Clark; M I Foreman; K A Kane; F M McDonald; J R Parratt
Journal:  J Pharmacol Methods       Date:  1980-06
View more
  18 in total

1.  Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats.

Authors:  M Veveris; M Dambrova; H Cirule; D Meirena; I Kalvinsh; J E Wikberg
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Antiarrhythmic drug research.

Authors:  M J A Walker
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.

Authors:  M A Rastegar; F Marchini; G Morazzoni; A Vegh; J G Papp; J R Parratt
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

4.  Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle.

Authors:  G Scholtysik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

5.  Antiarrhythmic effects of a benzothiazine derivative (SD-3211) and its stereoisomer (SA3212) in anaesthetized rats and isolated perfused rat hearts compared with bepridil.

Authors:  M Fukuchi; T Uematsu; S Nagashima; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

6.  Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin.

Authors:  W Song; B L Furman; J R Parratt
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Modulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?

Authors:  Márton Gönczi; Rita Papp; Mária Kovács; György Seprényi; Agnes Végh
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

8.  Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.

Authors:  A Bril; L Landais; B Gout
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

9.  Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.

Authors:  H Gülker; W Haverkamp; G Hindricks; F Bender
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

10.  A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.